MENU

Research & Development

차세대 유망 10대 기술선정 바이오산업의 핵심

Industry Convergences

Pharma

Personal
Care

Nutrition

Cosmeceuticals
Personalized
Medicine

Nutraceuticals

Personalized Diet

plus
arrow

주력 사업 분야

  • HUMAN MICROBIOME

  • CUREbiotics®

    · CURE ‘치료, 회복’

        - 질병의 치료

    · Moderate to Severe Disease

        - 未충족 의료수요가 높은 중증 질환 중심
         신약 개발

    · Prescriber driven

        - 임상 자료를 기반으로 한 과학적 증거

  • CAREbiotics®

    · CARE ‘돌봄, 보살핌’

        - 예방 및 관리

    · Borderline Disease

        - 前질환 or 경증 중심 건식

    · Consumer driven

        - 효능에 대한 체험을 통한 신뢰

No Journal Title Link
13 Frontiers in Cellular and Infection Microbiology(2017) Oral microbiota: microbial biomarkers of metabolic syndrome independent of host genetic factors MORE
12 Journal of Microbiology(2017) Bile salt hydrolase-mediated inhibitory effect of bacteroides ovatus on growth of clostridium difficile MORE
11 IJSEM(2017) Merdimonas faecis gen. nov., sp. nov., isolated from human faeces MORE
10 Molecular Brain(2017) Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia MORE
9 Cell Host & Microbe(2017) Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity. MORE
8 Gut(2016) The effect of heritability and host genetics on the gut microbiota and metabolic syndrome MORE
7 Scientific Reports(2016) Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans MORE
6 Genome Medicine(2016) Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes MORE
5 IJSEM(2015) Sellimonas intestinalis gen. nov., isolated from human faeces MORE
4 BMC Genomics(2015) Genetic associations and shared environmental effects on the skin microbiome of korean twins MORE
Top